FDA Recalls Blood Pressure Medication Due to Dissolution Issues

The FDA has issued a Class II recall for over 11,000 bottles of chlorthalidone tablets, a common blood pressure medication. The recall stems from the tablets failing dissolution specifications, meaning they may not properly dissolve in the body. This could lead to the medication being ineffective or delivering an incorrect dosage, and patients are advised to consult their healthcare provider before stopping use.